Industry Insights

  1. The Key To Unlocking Foreign Pharmaceutical Markets

    The opportunities in developing global markets appear limitless, but the obstacles surrounding them can be daunting. With issues ranging from language barriers to protecting intellectual property rights, each solution must be as unique as the country the work is developed in. Download this eBook to learn key strategies to unlock foreign pharma markets.

  2. What You Need To Know To Avoid Costly Delays In Your API Scale-Up

    If, in the course of the development process, undesirable effects occur that negatively impact API scale-up, it can prevent a company from delivering a product with reliable quality and efficacy. 

  3. Overcoming Purification Hurdles With Mixed-Mode Chromatography

    Current production systems can generate high titers of adenovirus, however, adenoviral vectors are tricky to purify on any significant scale despite their availability and abundance.

  4. Clinical Supply Chain Transformation Through Innovation

    Even with forecasting and building out a sizeable buffer inventory, clinical sites may still not always have the appropriate kits on hand to dispense to patients. Why?

  5. Bioburden Sources You Might Have Missed

    A problem with traditional mAb manufacturing is that there are so many potential entry points for microbial contamination. There are, however, ways to shut the door on contamination.

  6. Streamline Processes With Multivariate Analysis And Design Of Experiments

    Both multivariate analysis (MVA) and design of experiments (DoE) methods have numerous applications for simplifying the learning from large data sets and experimentation. 

  7. Implications Of Inaccurate Forecasting On Biologics Manufacturing

    Inaccurate demand forecasts can have significant implications for companies developing biologics. And, it is increasingly difficult to locate capacity to respond to demand changes.

  8. Top Five Tips For Chromatography Sample Preparation

    Chromatography comprises a group of molecular separation techniques commonly used in proteomics to isolate proteins of interest from heterogeneous samples. Despite the fact that these methods are purification strategies in their own right, it would be ill advised to introduce crude sample to your chromatography setup from the outset. The vast majority of samples encountered require some form of processing before they can be placed on the analytical instrument.

  9. Emerging Biotechs Take Control Of Their Destinies

    The recent Economist Intelligence Unit survey revealed that biopharma companies of all sizes share many of the same hopes and concerns. Yet many of the risk concerns and routes to growth are unique for small biotechs as they survey the changing industry landscape. We spoke with Ruta Waghmare – Global Director, Emerging Biotechnology at MilliporeSigma – about global funding trends, the evolution of virtual biotech companies, and taking control over your own molecule.

  10. Selecting The Optimal Resins For Adenovirus Process Purification

    The number of gene therapy–based treatments has grown significantly since they first appeared nearly three decades ago. This has created profound optimism about our potential to develop a cure for diseases such as cancer and AIDS.